Lund, Lars H.

2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 13,344

2018 ESC/EACTS guidelines on myocardial revascularization

Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal

Cardiac and Coronary Surgery TechniquesCoronary Interventions and Diagnostics

Cited by 7,167

Sotagliflozin in patients with diabetes and recent worsening heart failure

Bhatt, D. L., Szarek, M., Steg, P. G., Cannon, C. P., Leiter, L. A., McGuire, D. K., Lewis, J. B., Riddle, M. C., Voors, A. A., Metra, M., et al. (2021) · New England Journal of Medicine

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 1,868

The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth Adult Lung and Heart-Lung Transplantation Report-2017; focus theme: allograft ischemic time

Chambers, D. C., Yusen, R. D., Cherikh, W. S., Goldfarb, S. B., Kucheryavaya, A. Y., Khusch, K., Levvey, B. J., Lund, L. H., Meiser, B., Rossano, J. W., et al. (2017) · The Journal of Heart and Lung Transplantation

Transplantation: Methods and OutcomesOrgan Transplantation Techniques and Outcomes

Cited by 1,045

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V.-P., Parissis, J., Laroche, C., Piepoli, M. F., Fonseca, C., et al. (2017) · European Journal of Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 927

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF

Shah, S. J., Lam, C. S. P., Svedlund, S., Saraste, A., Hage, C., Tan, R.-S., Beussink-Nelson, L., Ljung Faxén, U., Fermer, M. L., Broberg, M. A., et al. (2018) · European Heart Journal

Cardiovascular Function and Risk FactorsCardiac Imaging and Diagnostics

Cited by 656

Characterization of the Inflammatory-Metabolic Phenotype of Heart Failure with a Preserved Ejection Fraction: A Hypothesis to Explain Influence of Sex on the Evolution and Potential Treatment of the Disease

Packer, M., Lam, C. S. P., Lund, L. H., Maurer, M. S., & Borlaug, B. A. (2020) · European Journal of Heart Failure

Heart Failure Treatment and ManagementCardiovascular Disease and Adiposity

Cited by 185

Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) project

Bandak, G., Sang, Y., Gasparini, A., Chang, A. R., Ballew, S. H., Evans, M., Arnlov, J., Lund, L. H., Inker, L. A., Coresh, J., et al. (2017) · Journal of the American Heart Association

Potassium and Related DisordersRenin-Angiotensin System Studies

Cited by 181

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

Jackson, A. M., Jhund, P. S., Anand, I. S., Düngen, H.-D., Lam, C. S. P., Lefkowitz, M. P., Linssen, G., Lund, L. H., Maggioni, A. P., Pfeffer, M. A., et al. (2021) · European Heart Journal

Heart Failure Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 156

Association between Use of Statins and Mortality in Patients with Heart Failure and Ejection Fraction of ≥50%

Alehagen, U., Benson, L., Edner, M., Dahlström, U., & Lund, L. H. (2015) · Circulation Heart Failure

Heart Failure Treatment and ManagementLipoproteins and Cardiovascular Health

Cited by 109

Prevalence and clinical significance of diabetes in asian versus white patients with heart failure

Bank, I. E. M., Gijsberts, C. M., Teng, T.-H. K., Benson, L., Sim, D., Yeo, P. S. D., Ong, H. Y., Jaufeerally, F., Leong, G. K. T., Ling, L. H., et al. (2017) · JACC Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 87

Microvascular endothelial dysfunction in heart failure with preserved ejection fraction

Lam, C. S. P., & Lund, L. H. (2016) · Heart

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 81

Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure

Schrage, B., Lund, L. H., Benson, L., Stolfo, D., Ohlsson, A., Westerling, R., Westermann, D., Strömberg, A., Dahlström, U., Braunschweig, F., et al. (2021) · Heart

Heart Failure Treatment and ManagementHealth disparities and outcomes

Cited by 50

Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology

Seferović, P., Farmakis, D., Bayes-Genis, A., Ben Gal, T., Böhm, M., Chioncel, O., Ferrari, R., Filippatos, G., Hill, L., Jankowska, E., et al. (2022) · European Journal of Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 24